Reproductive Health Posts
The Endocrine Society today issued a Clinical Practice Guideline (CPG) advising against the use of testosterone treatment in healthy women. Although the FDA approved testosterone therapy for the treatment of disorders involving the testes, pituitary and hypothalamus, it has not been approved for treating age-associated decrease in testosterone levels. The U.S. National Institute on Aging is also anticipated to release the results of research on the safety of testosterone. The study included nearly 800 older men with low testosterone and symptoms related to this condition, like anti aging supplements hgh (they said) sexual and physical dysfunction. Since the heart health of the men was monitored, the research is expected to shed more light on the safety of testosterone therapy.
The recent conflicting findings on testosterone treatment prompted Patel and his team to conduct a substantial systematic literature search for studies assessing the relationship between testosterone replacement therapy and cardiovascular events among men. An estimated 13 million men in the USA have problems with low testosterone, which happens when the body fails to make enough hormones because of a problem with the testicles or pituitary gland. This explains the sudden weight gain, clear aging and decline of energy of an individual.
No clear lower limit of testosterone was established; yet 15 ng per dL (0.5 nmol per L) commonly is used. One study 38 found that women with 0 to 10 ng per dL (0 to 0.3 nmol per L) had noticeably decreased sexual desire in all scenarios and absent or markedly reduced orgasms. Because of studies similar to this, supplemented with anecdotal evidence, many girls have been started on testosterone treatment. Most girls can expect to spend one third of their lives in the postmenopausal period. Depression, rage, moodiness, insomnia, and lack of well-being are common complaints of postmenopausal women.
Website URL: http://tinyurl.com/dy2gf6h